Cencora directors ink $111M deal related to opioid claims

10 hours ago 1
Opioid Crisis Newspaper Headline. Newspaper is on a Desk

KLH49/iStock via Getty Images

Cencora (NYSE:COR) directors have agreed to pay more than $111M in cash to resolve claims by pension funds that they failed to take adequate measures to prevent the company’s involvement in the U.S. opioid crisis, Bloomberg News reported, citing court documents.

Recommended For You

More Trending News

Read Entire Article